REPORTS

Let’s Pullulate and Expand Your Business

Biosimilar Drug Market - Global Professional Analysis and Forecast to 2026

Mar 13, 2020  |  220 PAGES  |  REPORT CODE: CMM271632
  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • INDUSTRY COVERAGE

The worldwide Biosimilar Drug market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 5.6% during the forecast period.

This report presents the market size and development trends by detailing the Biosimilar Drug market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Biosimilar Drug market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Biosimilar Drug industry and will help you to build a panoramic view of the industrial development.

Biosimilar Drug Market, By Type:

  • Injection

  • Tablets

  • Other Types

Biosimilar Drug Market, By Application:

  • Ankylosing Spondylitis

  • Tumor

  • Rheumatoid Arthrtis

  • Cardiovascular

  • Other Application

Some of the leading players are as follows:

  • Biotech Pharma

  • CP Guojian Pharma

  • Novartis

  • Amgen

  • Eli Lilly

Geographically, Major regions are analyzed in details are as follows:

  • North America

  • Europe

  • Asia Pacific

  • Latin America

  • Middle East & Africa

Table of Contents

1 Methodology and Scope

  • 1.1 Market Segmentation & Scope

    • 1.1.1 Technology Type

    • 1.1.2 Product

    • 1.1.3 Application

    • 1.1.4 Regional scope

    • 1.1.5 Estimates and forecast timeline

  • 1.2 Research Methodology

  • 1.3 Information Procurement

    • 1.3.1 Purchased database

    • 1.3.2 Internal database

    • 1.3.3 Secondary sources

    • 1.3.4 Primary research

    • 1.3.5 Details of primary research

  • 1.4 Information or Data Analysis

    • 1.4.1 Data analysis models

  • 1.5 Market Formulation & Validation

  • 1.6 Model Details

    • 1.6.1 Commodity flow analysis

    • 1.6.2 Volume price analysis

  • 1.7 List of Secondary Sources

  • 1.8 List of Abbreviations

2 Executive Summary

  • 2.1 Market Outlook

  • 2.2 Segment Outlook

3 Market Variables, Trends, & Scope

  • 3.1 Market Lineage Outlook

  • 3.1.1 Parent market outlook

    • 3.1.2 Ancillary market outlook

  • 3.2 Market Segmentation

    • 3.2.1 Analysis

  • 3.3 Market Dynamics

    • 3.3.1 Market driver analysis

    • 3.3.2 Market restraint analysis

    • 3.3.3 Industry opportunities

  • 3.4 Penetration & Growth Prospect Mapping

    • 3.4.1 Penetration & growth prospect mapping analysis

  • 3.5 Business Environment Analysis Tools

    • 3.5.1 Porter's five forces analysis

    • 3.5.2 PESTLE analysis

    • 3.5.3 Major deals & strategic alliances analysis

4 Biosimilar Drug Market: Technology Type Analysis

  • 4.1 Biosimilar Drug Technology Type Market Share Analysis, 2018 & 2026

  • 4.2 Biosimilar Drug Technology Type Market: Segment Dashboard

  • 4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment

    • 4.3.1 Injection

    • 4.3.2 Tablets

    • 4.3.3 Other Types

5 Biosimilar Drug Market: Product Analysis

  • 5.1 Biosimilar Drug Product Market Share Analysis, 2018 & 2026

  • 5.2 Biosimilar Drug Product Market: Segment Dashboard

  • 5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment

6 Biosimilar Drug Market: Application Analysis

  • 6.1 Biosimilar Drug Application Market Share Analysis, 2018 & 2026

  • 6.2 Biosimilar Drug Application Market: Segment Dashboard

  • 6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment

    • 6.3.1 Ankylosing Spondylitis

    • 6.3.2 Tumor

    • 6.3.3 Rheumatoid Arthrtis

    • 6.3.4 Cardiovascular

    • 6.3.5 Other Application

7 Biosimilar Drug Market: Regional Analysis

  • 7.1 Biosimilar Drug Regional Market Share Analysis, 2018 & 2026

  • 7.2 Biosimilar Drug Regional Market: Segment Dashboard

  • 7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)

  • 7.4 List of Players at Regional Level

    • 7.4.1 North America

    • 7.4.2 Europe

    • 7.4.3 Asia Pacific

  • 7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)

    • 7.5.1 North America

    • 7.5.2 Europe

    • 7.5.3 Asia Pacific

    • 7.5.4 Latin America

    • 7.5.5 MEA

  • 7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026

    • 7.6.1 North America

    • 7.6.2 Europe

    • 7.6.3 Asia Pacific

    • 7.6.4 Latin America

    • 7.6.5 Middle East & Africa

8 Competitive Analysis

  • 8.1 Recent Developments & Impact Analysis, by Key Market Participants

  • 8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)

  • 8.3 Vendor Landscape

    • 8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)

9 Company Profiles

  • 9.1 Biotech Pharma

    • 9.1.1 Biotech Pharma Company overview

    • 9.1.2 Financial performance

    • 9.1.3 Product benchmarking

    • 9.1.4 Strategic initiatives

    • 9.1.5 SWOT analysis

  • 9.2 CP Guojian Pharma

    • 9.2.1 CP Guojian Pharma Company overview

    • 9.2.2 Financial performance

    • 9.2.3 Product benchmarking

    • 9.2.4 Strategic initiatives

    • 9.2.5 SWOT analysis

  • 9.3 Novartis

    • 9.3.1 Novartis Company overview

    • 9.3.2 Financial performance

    • 9.3.3 Product benchmarking

    • 9.3.4 Strategic initiatives

    • 9.3.5 SWOT analysis

  • 9.4 Amgen

    • 9.4.1 Amgen Company overview

    • 9.4.2 Financial performance

    • 9.4.3 Product benchmarking

    • 9.4.4 Strategic initiatives

    • 9.4.5 SWOT analysis

  • 9.5 Eli Lilly

    • 9.5.1 Eli Lilly Company overview

    • 9.5.2 Financial performance

    • 9.5.3 Product benchmarking

    • 9.5.4 Strategic initiatives

    • 9.5.5 SWOT analysis

 

The List of Tables and Figures (Totals 68 Figures and 152 Tables)

  • Figure Injection Biosimilar Drug market, 2015 - 2026 (USD Million)

  • Figure Tablets Biosimilar Drug market, 2015 - 2026 (USD Million)

  • Figure Other Types Biosimilar Drug market, 2015 - 2026 (USD Million)

  • Figure Ankylosing Spondylitis market, 2015 - 2026 (USD Million)

  • Figure Tumor market, 2015 - 2026 (USD Million)

  • Figure Rheumatoid Arthrtis market, 2015 - 2026 (USD Million)

  • Figure Cardiovascular market, 2015 - 2026 (USD Million)

  • Figure Other Application market, 2015 - 2026 (USD Million)

  • Table List of players in North America

  • Table List of players in Europe

  • Table List of players in Asia Pacific

  • Table SWOT analysis

  • Table North America Biosimilar Drug market, by country, 2015 - 2026 (USD Million)

  • Table North America Biosimilar Drug market, by type, 2015 - 2026 (USD Million)

  • Table North America Biosimilar Drug market, by product, 2015 - 2026 (USD Million)

  • Table North America Biosimilar Drug market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table U.S. Biosimilar Drug market, by type, 2015 - 2026 (USD Million)

  • Table U.S. Biosimilar Drug market, by product, 2015 - 2026 (USD Million)

  • Table U.S. Biosimilar Drug market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Canada Biosimilar Drug market, by type, 2015 - 2026 (USD Million)

  • Table Canada Biosimilar Drug market, by product, 2015 - 2026 (USD Million)

  • Table Canada Biosimilar Drug market, by application, 2015 - 2026 (USD Million)

  • Table Europe Biosimilar Drug market, by country, 2015 - 2026 (USD Million)

  • Table Europe Biosimilar Drug market, by type, 2015 - 2026 (USD Million)

  • Table Europe Biosimilar Drug market, by product, 2015 - 2026 (USD Million)

  • Table Europe Biosimilar Drug market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table U.K. Biosimilar Drug market, by type, 2015 - 2026 (USD Million)

  • Table U.K. Biosimilar Drug market, by product, 2015 - 2026 (USD Million)

  • Table U.K. Biosimilar Drug market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Germany Biosimilar Drug market, by type, 2015 - 2026 (USD Million)

  • Table Germany Biosimilar Drug market, by product, 2015 - 2026 (USD Million)

  • Table Germany Biosimilar Drug market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table France Biosimilar Drug market, by type, 2015 - 2026 (USD Million)

  • Table France Biosimilar Drug market, by product, 2015 - 2026 (USD Million)

  • Table France Biosimilar Drug market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Italy Biosimilar Drug market, by type, 2015 - 2026 (USD Million)

  • Table Italy Biosimilar Drug market, by product, 2015 - 2026 (USD Million)

  • Table Italy Biosimilar Drug market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Spain Biosimilar Drug market, by type, 2015 - 2026 (USD Million)

  • Table Spain Biosimilar Drug market, by product, 2015 - 2026 (USD Million)

  • Table Spain Biosimilar Drug market, by application, 2015 - 2026 (USD Million)

  • Table Asia Pacific Biosimilar Drug market, by country, 2015 - 2026 (USD Million)

  • Table Asia Pacific Biosimilar Drug market, by type, 2015 - 2026 (USD Million)

  • Table Asia Pacific Biosimilar Drug market, by product, 2015 - 2026 (USD Million)

  • Table Asia Pacific Biosimilar Drug market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table China Biosimilar Drug market, by type, 2015 - 2026 (USD Million)

  • Table China Biosimilar Drug market, by product, 2015 - 2026 (USD Million)

  • Table China Biosimilar Drug market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Japan Biosimilar Drug market, by type, 2015 - 2026 (USD Million)

  • Table Japan Biosimilar Drug market, by product, 2015 - 2026 (USD Million)

  • Table Japan Biosimilar Drug market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table India Biosimilar Drug market, by type, 2015 - 2026 (USD Million)

  • Table India Biosimilar Drug market, by product, 2015 - 2026 (USD Million)

  • Table India Biosimilar Drug market, by application, 2015 - 2026 (USD Million)

  • Table Latin America Biosimilar Drug market, by country, 2015 - 2026 (USD Million)

  • Table Latin America Biosimilar Drug market, by type, 2015 - 2026 (USD Million)

  • Table Latin America Biosimilar Drug market, by product, 2015 - 2026 (USD Million)

  • Table Latin America Biosimilar Drug market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Brazil Biosimilar Drug market, by type, 2015 - 2026 (USD Million)

  • Table Brazil Biosimilar Drug market, by product, 2015 - 2026 (USD Million)

  • Table Brazil Biosimilar Drug market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Mexico Biosimilar Drug market, by type, 2015 - 2026 (USD Million)

  • Table Mexico Biosimilar Drug market, by product, 2015 - 2026 (USD Million)

  • Table Mexico Biosimilar Drug market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Argentina Biosimilar Drug market, by type, 2015 - 2026 (USD Million)

  • Table Argentina Biosimilar Drug market, by product, 2015 - 2026 (USD Million)

  • Table Argentina Biosimilar Drug market, by application, 2015 - 2026 (USD Million)

  • Table MEA Biosimilar Drug market, by country, 2015 - 2026 (USD Million)

  • Table MEA Biosimilar Drug market, by type, 2015 - 2026 (USD Million)

  • Table MEA Biosimilar Drug market, by product, 2015 - 2026 (USD Million)

  • Table MEA Biosimilar Drug market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table South Africa Biosimilar Drug market, by type, 2015 - 2026 (USD Million)

  • Table South Africa Biosimilar Drug market, by product, 2015 - 2026 (USD Million)

  • Table South Africa Biosimilar Drug market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Nigeria Biosimilar Drug market, by type, 2015 - 2026 (USD Million)

  • Table Nigeria Biosimilar Drug market, by product, 2015 - 2026 (USD Million)

  • Table Nigeria Biosimilar Drug market, by application, 2015 - 2026 (USD Million)

  • Table Recent Developments & Impact Analysis, by Key Market Participants

  • Table Recent Developments & Impact Analysis, by Key Market Participants

  • Table Company market position analysis

  • Table Company Profiles

  • Table Biotech Pharma Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table CP Guojian Pharma Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Novartis Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Amgen Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Eli Lilly Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

Report Purchase

reports
$3850
$7700
BUY NOWClick MeBUY NOW
top